{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:44:02Z","timestamp":1789242242475,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","jvsvenous.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jvsv.2024.101903","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T02:09:10Z","timestamp":1715738950000},"page":"101903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric\u00a0venous thrombosis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1299-5378","authenticated-orcid":false,"given":"Young-Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suehyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deokbi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-7424","authenticated-orcid":false,"given":"Hyung-Kee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-8310","authenticated-orcid":false,"given":"Woo-Sung","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2024.101903_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvsv.2024.101903_bib2","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvsv.2024.101903_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejvs.2017.01.010","article-title":"Editor's choice - management of the diseases of mesenteric arteries and veins: clinical practice guidelines of the European Society of Vascular surgery (ESVS)","volume":"53","author":"Bjorck","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvsv.2024.101903_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mayocp.2013.01.012","article-title":"Mesenteric venous thrombosis","volume":"88","author":"Singal","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvsv.2024.101903_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvsv.2024.101903_bib6","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jvsv.2024.101903_bib7","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2024.101903_bib8","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2020.01.039","article-title":"The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms","volume":"72","author":"Chaer","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvsv.2024.101903_bib9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC subcommittee control of anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2024.101903_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2024.101903_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1060028015591846","article-title":"Dosing of target-specific oral anticoagulants in special populations","volume":"49","author":"Morrill","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jvsv.2024.101903_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvsv.2024.101903_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jvs.2004.10.011","article-title":"Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study","volume":"41","author":"Acosta","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvsv.2024.101903_bib14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.6319","article-title":"Epidemiology, risk and prognostic factors in mesenteric venous thrombosis","volume":"95","author":"Acosta","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvsv.2024.101903_bib15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jth.12930","article-title":"Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study","volume":"13","author":"Riva","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2024.101903_bib16","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"Cohen","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jvsv.2024.101903_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11926-016-0623-7","article-title":"Direct oral anticoagulants use in antiphospholipid syndrome: are these drugs an effective and safe alternative to warfarin? A systematic review of the literature","volume":"18","author":"Dufrost","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jvsv.2024.101903_bib18","first-page":"6984","article-title":"Anticoagulant therapy in patients with antiphospholipid syndrome","volume":"11","author":"Capecchi","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jvsv.2024.101903_bib19","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvsv.2024.101903_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.14121","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study","volume":"39","author":"Noronha Ferreira","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jvsv.2024.101903_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvsv.2024.101903_bib22","first-page":"176","article-title":"Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)","volume":"22","year":"2021","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jvsv.2024.101903_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.thromres.2014.11.008","article-title":"Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial","volume":"135","author":"Prins","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvsv.2024.101903_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8432781","article-title":"Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis","volume":"2018","author":"Priyanka","year":"2018","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jvsv.2024.101903_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mayocp.2017.10.007","article-title":"Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location","volume":"93","author":"Janczak","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jvsv.2024.101903_bib26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X2400221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X2400221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:22:38Z","timestamp":1724480558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X2400221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213333X2400221X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2024.101903","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric\u00a0venous thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2024.101903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101903"}}